About Honz Pharma
Honz Pharma is a company based in Haikou (China) founded in 1994. The company has 659 employees. Honz Pharma offers products and services including Ear Thermometer and Blood Pressure Monitor.
- Headquarter Haikou, China
- Employees 659
- Stage Public
- SectorsHealthcare
- Website honz.com.cn
- Social LinkedIn
- Legal Name Honz Pharmaceutical Co., Ltd. Class A
- Annual Revenue$66.13 M (USD)-0.67as on Dec 31, 2025
- Net Profit-$32.87 M (USD)-6.82as on Dec 31, 2025
- EBITDA-$15.52 M (USD)-34.97as on Dec 31, 2025
- Employee Count659
Associated legal entities of Honz Pharma
Honz Pharma operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | – | – | – | View details |
Products & Services of Honz Pharma
Honz Pharma offers a comprehensive portfolio of products and services, including Ear Thermometer and Blood Pressure Monitor.
Ear thermometers are used for non-invasive temperature measurement in home settings
Blood pressure monitors are utilized for tracking vital signs in daily health management
People of Honz Pharma
1 people are tracked at Honz Pharma (1 in leadership); the tracked headcount is 659.
| Name | Role | Group |
|---|---|---|
Hongxi Liang | CEO | Leadership |
Complete people profiles for Honz Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Honz Pharma
Honz Pharma is a publicly listed company on the SZSE with ticker symbol 300086 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date28 May 2010
- Listed onSZSE: 300086
- Listed entityHonz Pharmaceutical Co., Ltd. Class A
- Exchange sectorHealth technology
- ISINCNE100000QM6
- Share price5.49 CNY (+2.43% on the day) · 2026-10-09
- Market capitalisation2,498,632,963.00 CNY
- EPS (diluted, trailing year)-0.46 CNY
- Volume (last session)20,603,090
Financials of Honz Pharma
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 463.0M CNY | -230.1M CNY | -108.6M CNY |
| 2024 | 466.1M CNY | -215.4M CNY | -80.5M CNY |
| 2023 | 734.4M CNY | 11.5M CNY | 141.4M CNY |
| 2022 | 524.9M CNY | -187.6M CNY | -83.5M CNY |
| 2021 | 831.2M CNY | 11.0M CNY | 47.7M CNY |
Balance sheet, profit and loss, cash flow and ratios of , are on its company page.
Detailed financial statements for Honz Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Latest news on Honz Pharma
Complete news archive for Honz Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Honz Pharma
10 companies that operate in the same segment as Honz Pharma (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Honz Pharma
Honz Pharma was founded in 1994.
Honz Pharma is headquartered in Haikou, China. It is registered at Haikou, Hainan, China.
Hongxi Liang is the current CEO of Honz Pharma.
Honz Pharma has 659 employees.
Annual revenue of Honz Pharma is $66.13M as on Dec 31, 2025.
Provider of accounting, tax, and advisory services for businesses. They offer a full suite of services including audit, business services, outsourced services, and advisory services encompassing business planning, tax planning, and corporate finance. Additional services cover payroll, VAT, corporation tax, and wealth management, including inheritance tax and estate planning. The firm also specializes in serving various sectors, such as charities, SMEs, and international subsidiaries. Their services are tailored to meet the evolving needs of clients, providing support across all aspects of financial management.
Honz Pharma offers Ear Thermometer and Blood Pressure Monitor.
Yes, Honz Pharma is publicly traded on SZSE under the ticker symbol 300086.
Honz Pharma operates through ,.